ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,154.88
0.53%
Dow Jones
38,707.28
0.08%
US Dollar vs MXN
16.9053
-0.46%
Brent Oil
83.23
0.13%
Bitcoin
63,256.31
-1.16%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xenon Pharmaceuticals Inc (XENE)

  7. Xenon Pharmaceuticals Inc (XENE) Noticias

XENE Xenon Pharmaceuticals Inc

43.83
0.08 (0.18%)
Última actualización: 10:11:40
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Xenon Pharmaceuticals Inc XENE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.08 0.18% 43.83 10:11:40
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
43.87 43.52 44.3672 43.75
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/5/202415:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
16/4/202407:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
04/4/202415:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
12/3/202415:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
08/3/202417:47EDGAR2Form 144 - Report of proposed sale of securities
08/3/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:27EDGAR2Form 8-K - Current report
07/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
07/3/202418:03EDGAR2Form 144 - Report of proposed sale of securities
05/3/202415:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
29/2/202415:10EDGAR2Form 8-K - Current report
29/2/202415:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202415:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
14/2/202408:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202407:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
03/1/202407:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
02/1/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:16GLOBEXenon Pharmaceuticals Announces Closing of $345.0 Million..
02/12/202311:01GLOBEXenon Pharmaceuticals Provides Updates on Neurology Pipeline..
30/11/202315:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/11/202315:15EDGAR2Form 8-K - Current report
29/11/202321:51GLOBEXenon Pharmaceuticals Announces Pricing of Upsized $300.0..
29/11/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/11/202315:03GLOBEXenon Pharmaceuticals Announces Proposed Public Offering
27/11/202306:03EDGAR2Form 8-K - Current report
27/11/202306:00GLOBEXenon Pharmaceuticals Announces Topline Results from Phase 2..
09/11/202315:06EDGAR2Form 8-K - Current report
09/11/202315:03GLOBEXenon Pharmaceuticals Provides Update on Partnered Program..
08/11/202315:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:11EDGAR2Form 8-K - Current report
08/11/202315:01GLOBEXenon Pharmaceuticals Reports Third Quarter 2023 Financial..
01/11/202315:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
09/10/202315:15GLOBEXenon Pharmaceuticals Announces Publication of Results from..
06/10/202307:30GLOBEXenon Pharmaceuticals to Present at Jefferies Inaugural..
14/9/202315:01GLOBEXenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
12/9/202315:30GLOBEXenon Pharmaceuticals Announces Upcoming Investor Webinar..
04/9/202307:30GLOBEXenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
31/8/202315:01GLOBEXenon Pharmaceuticals to Present at the Wells Fargo 2023..
10/8/202318:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202318:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/8/202317:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202317:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/8/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:16EDGAR2Form 8-K - Current report
09/8/202315:01GLOBEXenon Pharmaceuticals Reports Second Quarter 2023 Financial..
08/8/202315:07EDGAR2Form 8-K - Current report
08/8/202315:01GLOBEXenon Pharmaceuticals Expands Leadership on its Board of..
02/8/202315:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
06/6/202315:35GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 44th..

Su Consulta Reciente

NASDAQ
XENE
Xenon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados